What is a stock summary page? Click here for an overview.
Business Description
Propanc Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US74346N1072
Description
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -52.65 | |||||
| Debt-to-Equity | -0.29 | |||||
| Debt-to-EBITDA | -0.99 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -30.9 | |||||
| 3-Year EPS without NRI Growth Rate | -17.7 | |||||
| 3-Year FCF Growth Rate | -34.8 | |||||
| 3-Year Book Growth Rate | 22.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.14 | |||||
| 9-Day RSI | 30.61 | |||||
| 14-Day RSI | 39.81 | |||||
| 3-1 Month Momentum % | -52.08 | |||||
| 6-1 Month Momentum % | -68.06 | |||||
| 12-1 Month Momentum % | -97.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -38.7 | |||||
| Shareholder Yield % | -301.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1690.28 | |||||
| ROIC % | -65.67 | |||||
| 3-Year ROIIC % | 51.18 | |||||
| ROC (Joel Greenblatt) % | -6900 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.03 | |||||
| EV-to-EBITDA | -1.05 | |||||
| EV-to-FCF | -2.15 | |||||
| Earnings Yield (Greenblatt) % | -97.09 | |||||
| FCF Yield % | -695.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PPCB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Propanc Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -661.75 | ||
| Beta | 2.65 | ||
| 3-Year Sharpe Ratio | -1.33 | ||
| 3-Year Sortino Ratio | -1.8 | ||
| Volatility % | 134.52 | ||
| 14-Day RSI | 39.81 | ||
| 14-Day ATR ($) | 1.219444 | ||
| 20-Day SMA ($) | 6.643 | ||
| 12-1 Month Momentum % | -97.54 | ||
| 52-Week Range ($) | 2.76 - 269.99946 | ||
| Shares Outstanding (Mil) | 0.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Propanc Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Propanc Biopharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Propanc Biopharma Inc Frequently Asked Questions
What is Propanc Biopharma Inc(PPCB)'s stock price today?
The current price of PPCB is $5.68. The 52 week high of PPCB is $270.00 and 52 week low is $2.76.
When is next earnings date of Propanc Biopharma Inc(PPCB)?
The next earnings date of Propanc Biopharma Inc(PPCB) is .
Does Propanc Biopharma Inc(PPCB) pay dividends? If so, how much?
Propanc Biopharma Inc(PPCB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers